Worth reading
36Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
1600000
Shares (maximum number of common shares underlying the stock acquisition rights)Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of share acquisition rights as stock options
発行・処分する株式数
Up to 1,600,000 common shares of the Company, including 135,000 shares for directors of the Company and 50,000 shares for outside directors
Intended allottee
Directors and employees of the Company and directors and employees of the Company's subsidiaries (number by category: Not disclosed)
No monetary payment is required for the stock acquisition rights
Total Stock-Based Compensation
The fair value of the stock acquisition rights allocated to the Company's directors multiplied by the total number of rights allocated to directors serving on the allotment date. Amount: Not disclosed
Terms of the stock acquisition rights
Exercise price
Generally, the average closing price on each trading day in the month preceding the month containing the allotment date multiplied by 1.05, rounded up to the nearest yen, with the closing price on the allotment date as the floor. Adjustment provisions apply in the event of a stock split, consolidation or similar event
Exercise period
The 3-year period beginning on the date two years after the day following the resolution approving the allotment of the stock acquisition rights
Number of Stock Acquisition Rights
Up to 16,000 rights, including up to 1,350 rights for directors of the Company and 500 rights for outside directors. The number of unexercised rights remaining is Not disclosed
Reason for acquisition without consideration
If a holder of the stock acquisition rights no longer meets the exercise conditions, or if the general meeting of shareholders approves a merger in which the Company becomes the disappearing company, a share exchange in which the Company becomes a wholly owned subsidiary, or a similar transaction
Categories and Number of Persons Covered
Directors and employees of the Company and directors and employees of the Company's subsidiaries. The number of recipients is Not disclosed. Up to 1,350 rights, representing 135,000 underlying shares, will be allocated to directors, including up to 500 rights, representing 50,000 underlying shares, for outside directors
Basis for determining the amount to be paid
The exercise price will be the average closing price of the Company's common stock in ordinary trading on the Tokyo Stock Exchange on each trading day in the month preceding the month containing the allotment date, multiplied by 1.05. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply
Procedures under the Corporate Code of Conduct
The proposal will be submitted to the 17th Annual General Meeting of Shareholders scheduled for 18 June 2026, subject to approval
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of share acquisition rights as stock options |
| Number of shares to be issued or disposed of | Up to 1,600,000 common shares of the Company, including 135,000 shares for directors of the Company and 50,000 shares for outside directors |
| Issue price and disposal price | No monetary payment is required for the stock acquisition rights |
| Intended allottee | Directors and employees of the Company and directors and employees of the Company's subsidiaries (number by category: Not disclosed) |
| Basis for determining the amount to be paid | The exercise price will be the average closing price of the Company's common stock in ordinary trading on the Tokyo Stock Exchange on each trading day in the month preceding the month containing the allotment date, multiplied by 1.05. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply |
| Exercise price | Generally, the average closing price on each trading day in the month preceding the month containing the allotment date multiplied by 1.05, rounded up to the nearest yen, with the closing price on the allotment date as the floor. Adjustment provisions apply in the event of a stock split, consolidation or similar event |
| Exercise period | The 3-year period beginning on the date two years after the day following the resolution approving the allotment of the stock acquisition rights |
| Number of Stock Acquisition Rights | Up to 16,000 rights, including up to 1,350 rights for directors of the Company and 500 rights for outside directors. The number of unexercised rights remaining is Not disclosed |
| Reason for acquisition without consideration | If a holder of the stock acquisition rights no longer meets the exercise conditions, or if the general meeting of shareholders approves a merger in which the Company becomes the disappearing company, a share exchange in which the Company becomes a wholly owned subsidiary, or a similar transaction |
| Categories and Number of Persons Covered | Directors and employees of the Company and directors and employees of the Company's subsidiaries. The number of recipients is Not disclosed. Up to 1,350 rights, representing 135,000 underlying shares, will be allocated to directors, including up to 500 rights, representing 50,000 underlying shares, for outside directors |
| Total Stock-Based Compensation | The fair value of the stock acquisition rights allocated to the Company's directors multiplied by the total number of rights allocated to directors serving on the allotment date. Amount: Not disclosed |
| Procedures under the Corporate Code of Conduct | The proposal will be submitted to the 17th Annual General Meeting of Shareholders scheduled for 18 June 2026, subject to approval |
Items this document does not state (16)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To increase motivation and morale to improve the performance of the Group. The grant to directors is also intended to serve the purpose of stock options and is considered reasonable as remuneration, etc.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.